BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9861303)

  • 21. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart.
    Sakai S; Miyauchi T; Sakurai T; Kasuya Y; Ihara M; Yamaguchi I; Goto K; Sugishita Y
    Circulation; 1996 Mar; 93(6):1214-22. PubMed ID: 8653844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction.
    Dupuis J; Rouleau JL; Cernacek P
    Circulation; 1998 Oct; 98(16):1684-7. PubMed ID: 9778335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial contractile responsiveness to endothelin-1 in the post-infarction rat model of heart failure: effects of chronic quinapril.
    Qi XL; Sia YT; Stewart DJ; Wei G; Nguyen QT; Cernacek P; Picard P; Sirois M; Rouleau JL
    J Mol Cell Cardiol; 2001 Nov; 33(11):2023-35. PubMed ID: 11708846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of local production of endothelin-1 and of the ET(B)Receptor in the regulation of pulmonary vascular tone.
    Dupuis J; Jasmin JF; Prié S; Cernacek P
    Pulm Pharmacol Ther; 2000; 13(3):135-40. PubMed ID: 10873551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
    Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic effects of a novel, orally active endothelin receptor antagonist, T-0201, in dogs with congestive heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fukai D; Sawaki M; Maeda Y; Kinoshita M
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S236-8. PubMed ID: 9595447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart.
    Kobayashi T; Miyauchi T; Sakai S; Kobayashi M; Yamaguchi I; Goto K; Sugishita Y
    Am J Physiol; 1999 Apr; 276(4):H1197-206. PubMed ID: 10199843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor.
    Wang X; Ohnishi M; Wada A; Tsutamoto T; Sawaki M; Fujii M; Matsumoto T; Yamamoto T; Kurokawa K; Yamada H; Kinoshita M
    Life Sci; 2001 Oct; 69(21):2477-88. PubMed ID: 11693256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of endothelin-1 on alveolar fluid clearance and pulmonary edema formation in the rat.
    Berger MM; Rozendal CS; Schieber C; Dehler M; Zügel S; Bardenheuer HJ; Bärtsch P; Mairbäurl H
    Anesth Analg; 2009 Jan; 108(1):225-31. PubMed ID: 19095854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased cardiac and pulmonary endothelin-1 mRNA expression in canine pacing-induced heart failure.
    Huntington K; Picard P; Moe G; Stewart DJ; Albernaz A; Monge JC
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S424-6. PubMed ID: 9595502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow.
    Black SM; Mata-Greenwood E; Dettman RW; Ovadia B; Fitzgerald RK; Reinhartz O; Thelitz S; Steinhorn RH; Gerrets R; Hendricks-Munoz K; Ross GA; Bekker JM; Johengen MJ; Fineman JR
    Circulation; 2003 Sep; 108(13):1646-54. PubMed ID: 12963646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in hepatic endothelin-1 clearance in cirrhosis.
    Tran Duc AT; Schwab AJ; Simard A; Villeneuve L; Dupuis J
    Clin Sci (Lond); 2003 Aug; 105(2):227-34. PubMed ID: 12708965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of the endothelin system to the renal hypoperfusion associated with experimental congestive heart failure.
    Friedrich EB; Muders F; Luchner A; Dietl O; Riegger GA; Elsner D
    J Cardiovasc Pharmacol; 1999 Oct; 34(4):612-7. PubMed ID: 10511139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary hemodynamics and endothelin levels in pacing-induced heart failure: during rest and exercise.
    Kribbs SB; Clair MJ; Krombach RS; Hendrick JW; Thomas PB; Keever AT; Houch WV; Mukherjee R; Spinale FG
    J Card Fail; 1997 Dec; 3(4):263-70. PubMed ID: 9547440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of the endothelin system of lung myofibroblasts in congestive heart failure.
    Préfontaine A; Calderone A; Dupuis J
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):147-53. PubMed ID: 19528809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention.
    Schirger JA; Chen HH; Jougasaki M; Lisy O; Boerrigter G; Cataliotti A; Burnett JC
    Circulation; 2004 Jan; 109(2):249-54. PubMed ID: 14691038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure.
    Saad D; Mukherjee R; Thomas PB; Iannini JP; Basler CG; Hebbar L; O SJ; Moreland S; Webb ML; Powell JR; Spinale FG
    J Am Coll Cardiol; 1998 Nov; 32(6):1779-86. PubMed ID: 9822109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelin-1 in heart and pulmonary tissue in experimental heart failure.
    Sirviö ML; Helin K; Stewen P; Tikkanen I; Fyhrquist F
    Blood Press; 1997 Jul; 6(4):250-5. PubMed ID: 9296313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017.
    Na T; Dai DZ; Tang XY; Dai Y
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):39-49. PubMed ID: 17287947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.